Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing - Seite 2

About the Poster
Title: “Impact of Combinatorial Pharmacogenomic Testing on Hospitalization Rates in a Real-World Dataset of Patients with Major Depressive Disorder”
Authors: Andria L. Del Tredici, PhD; Priya Maheshwari, MS, RPh; Alexander Gutin, PhD; Devika Chawla, PhD; Katie Johansen Taber, PhD; Holly L. Johnson, PhD; Andrew A. Nierenberg, MD
Presenter: Priya Maheshwari, MS, RPh, senior medical information liaison at Myriad Genetics
Conference: American Association of Psychiatric Pharmacists (AAPP) conference in Orlando, FL; presented on Monday, April 8, 2024

About the Study
The study analyzed a data set generated by linking more than a half million de-identified patients who received the GeneSight test to administrative insurance claims from a nationwide data warehouse in the United States. Nearly 21,000 depressed patients met inclusion criteria to be in the study. The study authors then evaluated this data set with regard to medications prescribed before and after GeneSight testing, as well as hospitalization rates before and after GeneSight testing. Future analysis of the data will include investigating the impact of post-PGx medication selection on total cost of care for depression.

About the GeneSight Test
The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic test for more than 60 medications commonly prescribed for depression, anxiety, ADHD, and other psychiatric conditions. The GeneSight test can help inform clinicians about how a patient’s genes may impact how they metabolize and/or respond to certain psychiatric medications. Tens of thousands of clinicians have ordered the GeneSight test for more than two million patients in order to receive genetic information that is unique to each patient. The GeneSight test supplements other information considered by a clinician as part of a comprehensive medical assessment. Learn more at GeneSight.com.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.